These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9828634)

  • 1. [Fluorescein angiography of retinal changes in patients with neurofibromatosis 2].
    Hazim W; Mautner VF; Christiani B; Haase W
    Ophthalmologe; 1998 Oct; 95(10):687-90. PubMed ID: 9828634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinal Astrocytic Hamartoma in Neurofibromatosis Type 2 - Metaanalysis and a Case Report].
    Starosta DA; Lorenz B
    Klin Monbl Augenheilkd; 2018 Mar; 235(3):290-300. PubMed ID: 29534265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal changes associated with neurofibromatosis 2.
    Meyers SM; Gutman FA; Kaye LD; Rothner AD
    Trans Am Ophthalmol Soc; 1995; 93():245-52; discussion 252-7. PubMed ID: 8719681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis 2 leads to choroidal hyperfluorescence in fluorescein angiography.
    Feucht M; Richard G; Mautner VF
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):949-53. PubMed ID: 17186263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular findings associated with neurofibromatosis type II.
    Kaye LD; Rothner AD; Beauchamp GR; Meyers SM; Estes ML
    Ophthalmology; 1992 Sep; 99(9):1424-9. PubMed ID: 1407974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic hamartoma of the optic disc and multiple café-au-lait macules in a child with neurofibromatosis type 2.
    Sachdeva R; Rothner DA; Traboulsi EI; Hayden BC; Rychwalski PJ
    Ophthalmic Genet; 2010 Dec; 31(4):209-14. PubMed ID: 21067482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular fundus in neurofibromatosis type 2.
    Landau K; Yaşargil GM
    Br J Ophthalmol; 1993 Oct; 77(10):646-9. PubMed ID: 8218034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
    Feucht M; Kluwe L; Mautner VF; Richard G
    Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hamartoma of the retina and retinal pigment epithelium associated with neurofibromatosis type-1.
    Vianna RN; Pacheco DF; Vasconcelos MM; de Laey JJ
    Int Ophthalmol; 2001; 24(2):63-6. PubMed ID: 12201346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2.
    Chan CC; Koch CA; Kaiser-Kupfer MI; Parry DM; Gutmann DH; Zhuang Z; Vortmeyer AO
    J Pathol; 2002 Sep; 198(1):14-20. PubMed ID: 12210058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
    Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
    Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2.
    Bouzas EA; Parry DM; Eldridge R; Kaiser-Kupfer MI
    Retina; 1992; 12(2):103-7. PubMed ID: 1439239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epiretinal membranes indicate a severe phenotype of neurofibromatosis type 2.
    Sisk RA; Berrocal AM; Schefler AC; Dubovy SR; Bauer MS
    Retina; 2010 Apr; 30(4 Suppl):S51-8. PubMed ID: 20386093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Combined Hamartomas of the Retina and Retinal Pigment Epithelium as the Presenting Feature of Neurofibromatosis Type 2 (Wishart Type).
    Firestone BK; Arias JD; Shields CL; Shields JA
    J Pediatr Ophthalmol Strabismus; 2014 May; 51 Online():e33-6. PubMed ID: 26900706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
    Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
    Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral-Domain Optical Coherence Tomography Findings in Neurofibromatosis Type 2.
    Waisberg V; Rodrigues LO; Nehemy MB; Frasson M; de Miranda DM
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT262-7. PubMed ID: 27409481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Neuro-Ophthalmologists in the Care of Patients With Neurofibromatosis Type 2.
    Landau K
    J Neuroophthalmol; 2020 Sep; 40 Suppl 1():S51-S56. PubMed ID: 32796346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ocular presentation of neurofibromatosis 2.
    Ragge NK; Baser ME; Riccardi VM; Falk RE
    Eye (Lond); 1997; 11 ( Pt 1)():12-8. PubMed ID: 9246269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dragged disc syndrome in a patient presenting neurofibromatosis type II: a case study].
    Gicquel JJ; Vabres P; Mercié M; Klossek JM; Dighiero P
    J Fr Ophtalmol; 2005 May; 28(5):527-9. PubMed ID: 15976721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of epiretinal membrane in combined hamartomas of the retina and retinal pigment epithelium.
    Zhang X; Dong F; Dai R; Yu W
    Retina; 2010 Feb; 30(2):305-9. PubMed ID: 20175272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.